Viso Therapeutics Inc.

Naperville, IL

UEI
WKAZJJKL8HB3
CAGE
8SZ23
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2256 Wendt Cir, Naperville, IL 60564, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a peptide therapy for corneal wound healing R41EY034062 National Eye Institute (NIH) $601,778

Quick answers

Is Viso Therapeutics Inc. registered in SAM.gov?

Yes. Viso Therapeutics Inc.'s SAM.gov registration is active through January 21, 2027.

What is Viso Therapeutics Inc.'s most recent federal award?

Viso Therapeutics Inc.'s most recent federal grant award is Development of a peptide therapy for corneal wound healing (R41EY034062), from National Eye Institute (NIH), on September 1, 2022.

On GovTribe

See Viso Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login